Respirion Pharmaceuticals
PrivateLast Round
Grant
May 7, 2024
Total Funding Raised
$17.18M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Respirion Pharmaceuticals operates in Healthcare & Life Sciences and is based in Joondalup. Its latest recorded funding round was a Grant round in May 2024.
Respirion Pharmaceuticals is a biotechnology company that develops novel inhaled antibiotic therapies for the treatment of cystic fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Respirion Pharmaceuticals Comparables
Compare Respirion Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlgiPharma AS | 82% | |
| Spexis AG | 79% | |
| Laurent Pharmaceuticals | 78% |
For institutional investors. Book with your work email.
Respirion Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 7, 2024 | ||||
| Series A | Mar 15, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Respirion Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CUREator | Grant |
| Cystic Fibrosis Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 234% MoM.
- Jan 12, 2025
Monthly visitors increased 1209% MoM, from 34 to 445.
For institutional investors. Book with your work email.
Respirion Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Respirion Pharmaceuticals's valuation, stock price, and market status.
Is Respirion Pharmaceuticals a public or private company?
Respirion Pharmaceuticals is a private company.
What is the current stock price of Respirion Pharmaceuticals?
Respirion Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Respirion Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Respirion Pharmaceuticals worth (valuation)?
Valuation information for Respirion Pharmaceuticals is not publicly available.
Can I buy Respirion Pharmaceuticals stock?
Respirion Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Respirion Pharmaceuticals's last funding round?
Respirion Pharmaceuticals's most recent funding round was Grant on May 7, 2024.
Who are the main investors in Respirion Pharmaceuticals?
Key investors in Respirion Pharmaceuticals include CUREator, Cystic Fibrosis Foundation.
Will Respirion Pharmaceuticals IPO soon?
No public IPO plans have been announced for Respirion Pharmaceuticals.
How can I track Respirion Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Respirion Pharmaceuticals's shares on secondary markets.